CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
BIT:CELL - Euronext Milan - IT0005244618 - Common Stock - Currency: EUR
Overall CELL gets a fundamental rating of 6 out of 10. We evaluated CELL against 26 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL has an excellent financial health rating, but there are some minor concerns on its profitability. CELL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year CELL was profitable.
CELL had a positive operating cash flow in the past year.
In multiple years CELL reported negative net income over the last 5 years.
CELL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 2.42%, CELL is doing good in the industry, outperforming 65.38% of the companies in the same industry.
The Return On Equity of CELL (3.98%) is comparable to the rest of the industry.
CELL's Return On Invested Capital of 5.22% is in line compared to the rest of the industry. CELL outperforms 57.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.42% | ||
| ROE | 3.98% | ||
| ROIC | 5.22% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CELL has a Profit Margin of 2.27%. This is comparable to the rest of the industry: CELL outperforms 53.85% of its industry peers.
In the last couple of years the Profit Margin of CELL has declined.
CELL has a Operating Margin (4.17%) which is in line with its industry peers.
CELL's Operating Margin has declined in the last couple of years.
CELL has a better Gross Margin (40.12%) than 65.38% of its industry peers.
CELL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.17% | ||
| PM (TTM) | 2.27% | ||
| GM | 40.12% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CELL is destroying value.
Compared to 1 year ago, CELL has less shares outstanding
The number of shares outstanding for CELL has been increased compared to 5 years ago.
CELL has a better debt/assets ratio than last year.
2.2 Solvency
CELL has an Altman-Z score of 2.74. This is not the best score and indicates that CELL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.74, CELL is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
The Debt to FCF ratio of CELL is 2.15, which is a good value as it means it would take CELL, 2.15 years of fcf income to pay off all of its debts.
CELL's Debt to FCF ratio of 2.15 is fine compared to the rest of the industry. CELL outperforms 76.92% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that CELL is not too dependend on debt financing.
CELL has a Debt to Equity ratio of 0.15. This is amongst the best in the industry. CELL outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.15 | ||
| Altman-Z | 2.74 |
ROIC/WACC0.62
WACC8.45%
2.3 Liquidity
A Current Ratio of 2.22 indicates that CELL has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.22, CELL is doing good in the industry, outperforming 65.38% of the companies in the same industry.
CELL has a Quick Ratio of 1.53. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CELL (1.53) is better than 65.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.53 |
3. Growth
3.1 Past
CELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.66%, which is quite good.
CELL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.36% yearly.
Looking at the last year, CELL shows a small growth in Revenue. The Revenue has grown by 3.45% in the last year.
Measured over the past years, CELL shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)16.66%
EPS 3YN/A
EPS 5Y-21.36%
EPS Q2Q%-6.82%
Revenue 1Y (TTM)3.45%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%0.93%
3.2 Future
Based on estimates for the next years, CELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.11% on average per year.
CELL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.54% yearly.
EPS Next Y22.5%
EPS Next 2Y15.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.99%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.80, the valuation of CELL can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CELL indicates a rather cheap valuation: CELL is cheaper than 84.62% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CELL to the average of the S&P500 Index (26.29), we can say CELL is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.90, the valuation of CELL can be described as very cheap.
CELL's Price/Forward Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 92.31% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CELL to the average of the S&P500 Index (22.17), we can say CELL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.8 | ||
| Fwd PE | 5.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CELL is valued cheaper than 84.62% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CELL is valued cheaper than 96.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.98 | ||
| EV/EBITDA | 3.26 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CELL's earnings are expected to grow with 15.11% in the coming years.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CELL has a Yearly Dividend Yield of 3.21%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.06, CELL pays a better dividend. On top of this CELL pays more dividend than 92.31% of the companies listed in the same industry.
CELL's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.21% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CELL pays out 33.39% of its income as dividend. This is a sustainable payout ratio.
DP33.39%
EPS Next 2Y15.11%
EPS Next 3YN/A
BIT:CELL (6/2/2025, 7:00:00 PM)
2.95
+0.02 (+0.68%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners8.4%
Inst Owner ChangeN/A
Ins Owners16.79%
Ins Owner ChangeN/A
Market Cap64.52M
Analysts82.86
Price Target4.79 (62.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.21% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP33.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.8 | ||
| Fwd PE | 5.9 | ||
| P/S | 0.27 | ||
| P/FCF | 3.98 | ||
| P/OCF | 3 | ||
| P/B | 0.47 | ||
| P/tB | 1.16 | ||
| EV/EBITDA | 3.26 |
EPS(TTM)0.25
EY8.47%
EPS(NY)0.5
Fwd EY16.94%
FCF(TTM)0.74
FCFY25.14%
OCF(TTM)0.98
OCFY33.37%
SpS11.03
BVpS6.27
TBVpS2.54
PEG (NY)0.52
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.42% | ||
| ROE | 3.98% | ||
| ROCE | 5.96% | ||
| ROIC | 5.22% | ||
| ROICexc | 5.96% | ||
| ROICexgc | 13.29% | ||
| OM | 4.17% | ||
| PM (TTM) | 2.27% | ||
| GM | 40.12% | ||
| FCFM | 6.73% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y46.34%
ROICexcg growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.15 | ||
| Debt/EBITDA | 0.89 | ||
| Cap/Depr | 38.67% | ||
| Cap/Sales | 2.2% | ||
| Interest Coverage | 3.36 | ||
| Cash Conversion | 90.51% | ||
| Profit Quality | 296.98% | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.53 | ||
| Altman-Z | 2.74 |
F-Score7
WACC8.45%
ROIC/WACC0.62
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.66%
EPS 3YN/A
EPS 5Y-21.36%
EPS Q2Q%-6.82%
EPS Next Y22.5%
EPS Next 2Y15.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.45%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%0.93%
Revenue Next Year5.99%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.24%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year52.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.93%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y65%
OCF growth 3Y4.12%
OCF growth 5Y1.2%